Current and Emerging Therapeutic Strategies for Hypertrophic Cardiomyopathy: From Medication to Gene Editing
Abstract
The management of hypertrophic cardiomyopathy (HCM) has evolved with the development of new pharmacological agents, invasive therapies, and gene-editing techniques. This paper provides a detailed overview of the current treatment landscape, including beta-blockers, calcium channel blockers, and myosin inhibitors. It also examines the use of septal reduction therapy, such as surgical myectomy and alcohol septal ablation, in symptomatic patients. The study further explores emerging therapies like CRISPR/Cas9 gene editing, which holds promise for directly correcting pathogenic mutations. By highlighting both traditional and innovative treatment options, this paper aims to inform clinicians about the best strategies for individualized patient care and the potential for future curative therapies.
References
Herda, T. J., Cramer, J. T., Ryan, E. D., McHugh, M. P., & Stout, J. R. (2008). Acute effects of static versus dynamic stretching on isometric peak torque, electromyography, and mechanomyography of the biceps femoris muscle. Journal of Strength and Conditioning Research, 22(3), 809-817. https://doi.org/10.1519/JSC.0b013e31816a83a4
Hill, A. V. (1938). The heat of shortening and the dynamic constants of muscle. Proceedings of the Royal Society of London. Series B, Biological Sciences, 126(843), 136-195. https://doi.org/10.1098/rspb.1938.0050
Huxley, A. F. (1957). Muscle structure and theories of contraction. Progress in Biophysics and Biophysical Chemistry, 7, 255-318.
Jones, D. A., & Rutherford, O. M. (1987). Human muscle strength training: The effects of three different regimens and the nature of the resultant changes. Journal of Physiology, 391(1), 1-11. https://doi.org/10.1113/jphysiol.1987.sp016717
Kawakami, Y., Ichinose, Y., & Fukunaga, T. (1998). Architectural and functional features of human triceps surae muscles during contraction. Journal of Applied Physiology, 85(2), 398-404. https://doi.org/10.1152/jappl.1998.85.2.398
Kubo, K., Kanehisa, H., & Fukunaga, T. (2002). Effects of resistance and stretching training programs on the viscoelastic properties of human tendon structures in vivo. Journal of Applied Physiology, 92(2), 595-601. https://doi.org/10.1152/japplphysiol.00658.2001
McArdle, W. D., Katch, F. I., & Katch, V. L. (2010). Exercise Physiology: Nutrition, Energy, and Human Performance (7th ed.). Lippincott Williams & Wilkins.
Muthu, P., Mettikolla, P., Calander, N., Luchowski, R., Gryczynski, I., Gryczynski, Z., ... & Borejdo, J. (2010). Single molecule kinetics in the familial hypertrophic cardiomyopathy D166V mutant mouse heart. Journal of molecular and cellular cardiology, 48(5), 989-998.
Krupa, A., Fudala, R., Stankowska, D., Loyd, T., Allen, T. C., Matthay, M. A., ... & Kurdowska, A. K. (2009). Anti-chemokine autoantibody: chemokine immune complexes activate endothelial cells via IgG receptors. American journal of respiratory cell and molecular biology, 41(2), 155-169.
Mettikolla, P., Calander, N., Luchowski, R., Gryczynski, I., Gryczynski, Z., Zhao, J., ... & Borejdo, J. (2011). Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin. Journal of theoretical biology, 284(1), 71-81.
Mettikolla, P., Calander, N., Luchowski, R., Gryczynski, I., Gryczynski, Z., & Borejdo, J. (2010). Kinetics of a single cross-bridge in familial hypertrophic cardiomyopathy heart muscle measured by reverse Kretschmann fluorescence. Journal of Biomedical Optics, 15(1), 017011-017011.
Mettikolla, P., Luchowski, R., Gryczynski, I., Gryczynski, Z., Szczesna-Cordary, D., & Borejdo, J. (2009). Fluorescence lifetime of actin in the familial hypertrophic cardiomyopathy transgenic heart. Biochemistry, 48(6), 1264-1271.
Mettikolla, P., Calander, N., Luchowski, R., Gryczynski, I., Gryczynski, Z., & Borejdo, J. (2010). Observing cycling of a few cross‐bridges during isometric contraction of skeletal muscle. Cytoskeleton, 67(6), 400-411.
Muthu, P., Mettikolla, P., Calander, N., & Luchowski, R. 458 Gryczynski Z, Szczesna-Cordary D, and Borejdo J. Single molecule kinetics in, 459, 989-998.
Borejdo, J., Mettikolla, P., Calander, N., Luchowski, R., Gryczynski, I., & Gryczynski, Z. (2021). Surface plasmon assisted microscopy: Reverse kretschmann fluorescence analysis of kinetics of hypertrophic cardiomyopathy heart.
Mettikolla, Y. V. P. (2010). Single molecule kinetics in familial hypertrophic cardiomyopathy transgenic heart. University of North Texas Health Science Center at Fort Worth.
Mettikolla, P., Luchowski, R., Chen, S., Gryczynski, Z., Gryczynski, I., Szczesna-Cordary, D., & Borejdo, J. (2010). Single Molecule Kinetics in the Familial Hypertrophic Cardiomyopathy RLC-R58Q Mutant Mouse Heart. Biophysical Journal, 98(3), 715a.
